Novo Nordisk CEO to testify at Senate hearing over high weight loss drug prices
September 24, 2024 at 07:00 AM EDT
Sen. Bernie Sanders argues that Novo Nordisk charges Americans substantially higher prices for its drugs than it does for patients in other countries.